NICE clinical guideline 86. Coeliac disease: Recognition and assessment of coeliac disease

Archives of Disease in Childhood

Volumn 95, Issue 4, 2010, Pages 312-313

  Jones, Hayley J ^a   Warner, Justin T ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADOLESCENT; CELIAC DISEASE; CHILD; DIABETIC PATIENT; DISEASE SEVERITY; GLUTEN FREE DIET; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING; SYMPTOM;

ADOLESCENT; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC;

EID: 77950323741     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.173849     Document Type: Letter

References (4)

1. NICE clinical guideline CG86. Coeliac disease: recognition and assessment of coeliac disease. 2009. www.nice.org.uk/CG86 (accessed July 2009).
2. National Institute for Clinical Excellence. Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults. London: National Institute for Clinical Excellence (NICE), 2004:112.
3. Barera G, Bonfanti R, Viscardi M, et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2002;109:833-838
4. Deja G, Myrda A, Jarosz-Chobot P, et al. The assessment of autoimmunological status and prevalence of different forms of celiac disease among children with type 1 diabetes mellitus and celiac disease. Mediators Inflamm 2008;2008:285989.